CareCloud (NASDAQ:CCLD – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare CareCloud to similar businesses based on the strength of its profitability, risk, valuation, analyst recommendations, dividends, earnings and institutional ownership.
Volatility & Risk
CareCloud has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Comparatively, CareCloud’s rivals have a beta of 1.11, meaning that their average stock price is 11% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for CareCloud and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CareCloud | 0 | 1 | 1 | 0 | 2.50 |
| CareCloud Competitors | 453 | 1534 | 2743 | 89 | 2.51 |
As a group, “Healthcare Technology” companies have a potential upside of 43.47%. Given CareCloud’s rivals stronger consensus rating and higher possible upside, analysts clearly believe CareCloud has less favorable growth aspects than its rivals.
Institutional and Insider Ownership
10.2% of CareCloud shares are owned by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares CareCloud and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| CareCloud | $120.50 million | $10.80 million | 20.23 |
| CareCloud Competitors | $341.86 million | -$24.15 million | 12.77 |
CareCloud’s rivals have higher revenue, but lower earnings than CareCloud. CareCloud is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares CareCloud and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CareCloud | 7.36% | 32.32% | 16.30% |
| CareCloud Competitors | -754.24% | -30.01% | -15.66% |
Summary
CareCloud rivals beat CareCloud on 7 of the 13 factors compared.
CareCloud Company Profile
CareCloud, Inc. (NASDAQ: CCLD) provides cloud-based health care information technology and revenue cycle management services to medical practices, hospitals and other health care organizations. The company’s solutions are designed to help providers manage administrative, clinical and financial operations through integrated software and technology-enabled services. Its offerings include electronic health records, practice management, medical billing and revenue cycle management, patient engagement tools, telehealth capabilities and related health care technology services.
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.
